bioMerieux (BMXMF) News Today $149.38 +14.33 (+10.61%) As of 07/25/2025 09:30 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock BMXMF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period bioMerieux (OTCMKTS:BMXMF) Stock Price Down 3.5% - Should You Sell?July 22, 2025 | marketbeat.combioMerieux (OTCMKTS:BMXMF) Shares Gap Down - Should You Sell?July 21, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Sets New 1-Year High - What's Next?June 10, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Shares Cross Above 50-Day Moving Average - Should You Sell?May 19, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Lowered to "Hold" Rating by Royal Bank of CanadaMay 10, 2025 | marketbeat.comRBC Capital abaisse la note de BioMerieux en raison de préoccupations liées au change et aux tarifsMay 7, 2025 | fr.investing.comBiomerieux SAMay 4, 2025 | fr.investing.comShort Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Expands By 100.9%April 30, 2025 | marketbeat.comKepler Capital Keeps Their Buy Rating on bioMerieux (0RUG)April 19, 2025 | markets.businessinsider.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High - Time to Buy?April 16, 2025 | marketbeat.comActivist investor Fivespan takes stake in Qiagen - BloombergApril 15, 2025 | msn.comRBC Capital Sticks to Their Buy Rating for bioMerieux (0RUG)April 13, 2025 | markets.businessinsider.combioMérieux (OTCMKTS:BMXMF) Stock Passes Above 50 Day Moving Average - Time to Sell?April 6, 2025 | marketbeat.combioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistanceMarch 20, 2025 | uk.finance.yahoo.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Up 43.1% in FebruaryMarch 17, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Hits New 1-Year High - Here's WhyMarch 11, 2025 | marketbeat.comBioMerieux SA (BMXMF) Full Year 2024 Earnings Call Highlights: Surpassing Growth Targets and ...March 8, 2025 | finance.yahoo.combioMérieux S.A. (BMXMF) Q4 2024 Earnings Call TranscriptMarch 7, 2025 | seekingalpha.combioMérieux (OTCMKTS:BMXMF) Stock Price Passes Above 50 Day Moving Average - What's Next?March 6, 2025 | marketbeat.comQiagen files patent infringement complaint against bioMerieuxMarch 3, 2025 | markets.businessinsider.comKepler Capital Sticks to Their Buy Rating for bioMerieux (0RUG)March 3, 2025 | markets.businessinsider.comUBS Reaffirms Their Buy Rating on bioMerieux (0RUG)February 28, 2025 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on bioMerieux (0RUG)February 27, 2025 | markets.businessinsider.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Large Drop in Short InterestFebruary 17, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Reaches New 1-Year High - Time to Buy?February 4, 2025 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Decrease in Short InterestJanuary 30, 2025 | marketbeat.comL'objectif de cours de BioMerieux relevé, recommandation d'achat sur des résultats solides au T4January 22, 2025 | fr.investing.comBioMerieux stock target upgraded, buy rating on robust Q4 resultsJanuary 22, 2025 | msn.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest UpdateJanuary 16, 2025 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Growth in Short InterestDecember 15, 2024 | marketbeat.comRBC Capital attribue une note de surperformance à l'action BioMerieuxDecember 11, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Shares Up 3% - What's Next?November 30, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below Fifty Day Moving Average - What's Next?November 8, 2024 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 20.2% in OctoberOctober 28, 2024 | marketbeat.comLe large parc installé de BioMerieux considéré comme un avantage clé - HSBCOctober 17, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below 50 Day Moving Average - Time to Sell?October 9, 2024 | marketbeat.comShort Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Drops By 26.8%September 28, 2024 | marketbeat.combioMérieux S.A. (BMXMF)September 18, 2024 | finance.yahoo.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $122.52September 11, 2024 | marketbeat.comBerenberg Bank Keeps Their Buy Rating on bioMerieux (0RUG)September 11, 2024 | markets.businessinsider.comKepler Capital Reaffirms Their Buy Rating on bioMerieux (0RUG)September 7, 2024 | markets.businessinsider.comUBS maintient sa note d'achat sur BioMerieux, voit la force de la R&DSeptember 6, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $120.00September 5, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Hits New 52-Week High at $119.62August 28, 2024 | marketbeat.combioMerieux (0RUG) Gets a Buy from Kepler CapitalAugust 28, 2024 | markets.businessinsider.comHologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among ThemAugust 27, 2024 | seekingalpha.comUBS Group Upgrades bioMérieux (OTCMKTS:BMXMF) to "Strong-Buy"August 24, 2024 | marketbeat.comUBS voit l'action BioMerieux prête à croître grâce à la plateforme disruptive SPOTFIREAugust 22, 2024 | fr.investing.comBaxter International Inc. (BAX)July 27, 2024 | finance.yahoo.comBioMerieux SA BIMMay 16, 2024 | morningstar.comM Get bioMerieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address BMXMF Media Mentions By Week BMXMF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMXMF News Sentiment▼0.711.07▲Average Medical News Sentiment BMXMF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMXMF Articles This Week▼20▲BMXMF Articles Average Week Get bioMerieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies COR News Today LH News Today NTRA News Today ERFSF News Today CHEOY News Today SOLV News Today ICLR News Today RVTY News Today VTRS News Today MEDP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BMXMF) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioMerieux Please log in to your account or sign up in order to add this asset to your watchlist. Share bioMerieux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
